CHAPEL HILL, NC, UNITED STATES - Sep 30, 2014 -  

WHAT:  Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services, including risk-based monitoring (RBM) strategies, at the Outsourcing in Clinical Trials (OCT) New England Conference taking place October 7-8 in Boston, Massachusetts.

Attendees are invited to stop by Rho’s booth (#54) to meet with RBM expert Lauren McGurk, who has more than 17 years of experience in all phases of development, including creating and executing RBM plans. Risk-based approaches can actually reduce the risks in clinical trials by focusing on the most critical data elements and processes necessary to achieve study objectives.

McGurk will also be speaking at the event, presenting “Strategies for Clinical, Data, and Statistical Team Integration and Planning to Improve Data Quality and Mitigate Risks.” During her talk, she will discuss the development of robust and adaptive clinical monitoring and risk management plans; ways to establish early communication pathways between clinical, data and statistical team members; how to enhace quality management at the site level to support risk-based strategies; and explore the use of web portals to enhance study management.

WHO: Rho expert(s) at OCT:

• Lauren McGurk, Senior Clinical Research Associate II
• Jessica Barons, Director, Business Development

WHEN:  October 7-8, 2014

WHERE:  Westin Boston Waterfront

                425 Summer Street

                Boston, MA 02210

DETAILS:  For media inquiries please contact Bernadette Chepega Miller at Largemouth Communications, (703) 297-5992, bernadette@largemouthpr.com.

ABOUT:  Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 30 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.

###